Abstract
The administration of inhaled corticosteroids (ICS) might cause dose-dependent hyperglycemia and poorer glycemic control in patients with earlier diagnosed carbohydrate metabolism disorders. However, not in all patients, ICS affects glycated hemoglobin, the main marker of diabetes mellitus. Objective: to assess the effect of ICS on the glycemic profile of patients with type 1 diabetes mellitus (DM1). We demonstrated how ICS can affect the glycemic profile in DM1 patients on the example of two cases. ICS can cause short-term increase in blood glucose in some DM1 patients, comparable to postprandial levels; however, ICS does not compromise glycemic control. Nevertheless, such cases have to be managed by a pulmonologist and a pediatric endocrinologist for individual correction of therapy. Key words: type 1 diabetes mellitus, children, inhaled corticosteroids, bronchial obstruction, carbohydrate metabolism, glycemic profile
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
